Solinís MÁ - Search Results

1

Nanostructured lipid carriers: Promising drug delivery systems for future clinics.

Beloqui A, Solinís MÁ, Rodríguez-Gascón A, Almeida AJ, Préat V. Beloqui A, et al. Among authors: solinis ma. Nanomedicine. 2016 Jan;12(1):143-61. doi: 10.1016/j.nano.2015.09.004. Epub 2015 Sep 26. Nanomedicine. 2016. PMID: 26410277 Review.

2

In vivo pharmacokinetic-pharmacodynamic relationship and in vitro equivalence of two oral furosemide tablet formulations.

Cuadrado A, Rodríguez Gascón A, Hernández RM, Castilla AM, de la Maza A, Yánez C, López de Ocáriz A, Solinís MA, Pedraz JL. Cuadrado A, et al. Among authors: solinis ma. Arzneimittelforschung. 2003;53(5):321-9. doi: 10.1055/s-0031-1297116. Arzneimittelforschung. 2003. PMID: 12854359 Clinical Trial.

3

[Pharmacokinetic/pharmacodynamic analysis of antibiotic therapy in dentistry and stomatology].

Isla A, Canut A, Rodríguez-Gascón A, Labora A, Ardanza-Trevijano B, Solinís MA, Pedraz JL. Isla A, et al. Among authors: solinis ma. Enferm Infecc Microbiol Clin. 2005 Mar;23(3):116-21. doi: 10.1157/13072159. Enferm Infecc Microbiol Clin. 2005. PMID: 15757581 Review. Spanish.

4

Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy.

Isla A, Rodríguez-Gascón A, Trocóniz IF, Bueno L, Solinís MA, Maynar J, Sánchez-Izquierdo JA, Pedraz JL. Isla A, et al. Among authors: solinis ma. Clin Pharmacokinet. 2008;47(3):173-80. doi: 10.2165/00003088-200847030-00003. Clin Pharmacokinet. 2008. PMID: 18307371 Clinical Trial.

5

Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway.

Delgado D, del Pozo-Rodríguez A, Solinís MÁ, Rodríguez-Gascón A. Delgado D, et al. Among authors: solinis ma. Eur J Pharm Biopharm. 2011 Nov;79(3):495-502. doi: 10.1016/j.ejpb.2011.06.005. Epub 2011 Jun 25. Eur J Pharm Biopharm. 2011. PMID: 21726641

6

Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery.

Isla A, Trocóniz IF, de Tejada IL, Vázquez S, Canut A, López JM, Solinís MÁ, Rodríguez Gascón A. Isla A, et al. Among authors: solinis ma. Eur J Clin Pharmacol. 2012 May;68(5):735-45. doi: 10.1007/s00228-011-1206-1. Epub 2012 Jan 15. Eur J Clin Pharmacol. 2012. PMID: 22246211

7

Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier.

Beloqui A, Solinís MÁ, Gascón AR, del Pozo-Rodríguez A, des Rieux A, Préat V. Beloqui A, et al. Among authors: solinis ma. J Control Release. 2013 Mar 10;166(2):115-23. doi: 10.1016/j.jconrel.2012.12.021. Epub 2012 Dec 22. J Control Release. 2013. PMID: 23266764

8

Lipid nanoparticles as drug/gene delivery systems to the retina.

del Pozo-Rodríguez A, Delgado D, Gascón AR, Solinís MÁ. del Pozo-Rodríguez A, et al. Among authors: solinis ma. J Ocul Pharmacol Ther. 2013 Mar;29(2):173-88. doi: 10.1089/jop.2012.0128. Epub 2013 Jan 3. J Ocul Pharmacol Ther. 2013. PMID: 23286300 Review.

9

Biodistribution of Nanostructured Lipid Carriers (NLCs) after intravenous administration to rats: influence of technological factors.

Beloqui A, Solinís MA, Delgado A, Evora C, del Pozo-Rodríguez A, Rodríguez-Gascón A. Beloqui A, et al. Among authors: solinis ma. Eur J Pharm Biopharm. 2013 Jun;84(2):309-14. doi: 10.1016/j.ejpb.2013.01.029. Epub 2013 Feb 24. Eur J Pharm Biopharm. 2013. PMID: 23461861

10

Gene therapy for fabry disease: a review of the literature.

Ruiz de Garibay AP, Solinís MA, Rodríguez-Gascón A. Ruiz de Garibay AP, et al. Among authors: solinis ma. BioDrugs. 2013 Jun;27(3):237-46. doi: 10.1007/s40259-013-0032-7. BioDrugs. 2013. PMID: 23575647 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page